J&J to Pay $5.9 Million Risperdal Penalty

Montana Rules J&J Subsidiaries to Pay Millions for Risperdal Marketing A subsidiary of Johnson & Johnson has agreed to pay $5.9 million after a Montana court ruled that Risperdal was marketed off-label. The settlement claims that Janssen Pharmaceuticals, Risperdal’s manufacturers, marketed Risperdal for inappropriate uses in children and … [Read more...]

BestLawyers.comAVBetter Business Bureau